CIK 0001262104 · Non-accelerated filer<br>Smaller reporting company
Lite Strategy, Inc.
Sign in to watch- Ticker
- LITS
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510407811
- Phone
- 858-369-7100
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- MEI Pharma, Inc., MARSHALL EDWARDS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-03 | GHALIE RICHARD G Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2021-02-23 | DRISCOLL FREDERICK W Director | Sale | −25,000 | $4.03 | $101K | 37,500 |
| 2020-07-23 | GOLD DANIEL P PHD Chief Executive Officer | Option exercise | +12,000 | $1.57 | $19K | 453,632 |
| 2020-07-23 | GOLD DANIEL P PHD Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −12,000 | 275,500 | ||
| 2020-07-02 | White Christine Anna Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | Glover Nicholas Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | Reynolds Thomas C Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | DRISCOLL FREDERICK W Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | Urso David M Chief Operating Officer & GC | Grant or award | +50,000 | 74,106 | ||
| 2020-07-02 | Urso David M Chief Operating Officer & GC | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 | ||
| 2020-07-02 | Mass Robert D. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2020-07-02 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | Drazba Brian G. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2020-07-02 | Clemens Kevan Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | Baltic Charles V. III Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-07-02 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award | +80,000 | 441,632 | ||
| 2020-07-02 | GOLD DANIEL P PHD Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +680,000 | 680,000 | ||
| 2020-07-02 | Cohen Cheryl Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-04-10 | Cohen Cheryl Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2019-12-19 | Reynolds Thomas C Director | Purchase | +10,000 | $1.60 | $16K | 10,000 |
Page 6 of 13 · 252 trades